Highlights and Quick Summary
- Capex to Sales for the quarter ending December 30, 2011 was 0.0 (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Capex to Sales decreased by NaN%
- Twelve month Capex to Sales ending December 30, 2011 was 0.0 (a NaN% decrease compared to previous quarter)
- Twelve month trailing Capex to Sales decreased by NaN% year-over-year
Trailing Capex to Sales for the last four month:
|30 Dec '11||30 Dec '10||29 Sep '10||29 Jun '10|
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.
Historical Capex to Sales of HST Global Inc.Most recent Capex to Salesof HSTC including historical data for past 10 years.
Interactive Chart of Capex to Sales of HST Global Inc.
HST Global Inc. Capex to Sales for the past 10 Years (both Annual and Quarterly)
Business Profile of HST Global Inc.
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.